Loading organizations...
Opya delivers personalized early intervention autism therapies, integrating individualized Applied Behavior Analysis (ABA), speech, and occupational services. The company employs a technology-enabled approach to enhance treatment delivery, providing these crucial interventions for young children. Its model focuses on comprehensive care designed to support developmental progress during critical early childhood years.
Jonathan Wright founded Opya in 2015, driven by the profound insight gained from his mother's lifelong dedication to autism care. This foundational inspiration underscored the necessity for more accessible and effective therapeutic solutions, leading Wright to establish a company dedicated to transforming autism treatment through an integrated service model.
Opya primarily serves children aged 18 months to six years diagnosed with autism spectrum disorder and their families. The company's mission is rooted in a commitment to supporting every individual and family within its care. Its long-term vision aims to redefine autism care by seamlessly connecting innovative treatment methodologies with advanced technological applications.
Opya has raised $19.0M across 2 funding rounds.
Opya has raised $19.0M in total across 2 funding rounds.
Opya has raised $19.0M across 2 funding rounds. Most recently, it raised $15.0M Series A in August 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 1, 2021 | $15M Series A | — | Altitude Ventures, BIP Capital, Divergent Investments, Surface Ventures, Austin Poole, Raven ONE Ventures, SB Opportunity Fund, The Disability Opportunity Fund | Announced |
| Sep 1, 2017 | $4M Seed | — | Bootstrap Venture Partners, Keshif Ventures, Surface Ventures | Announced |
Opya is a San Mateo-based healthcare technology company specializing in early intervention therapy for children with autism spectrum disorder (ASD), aged 18 months to 6 years. It provides intensive Applied Behavior Analysis (ABA) therapy in the home, complemented by speech, occupational, and feeding therapies, all enhanced by digital tools for clinician-parent collaboration and data tracking. Opya serves newly diagnosed neurodiverse children and their families, addressing critical gaps in autism care through personalized, high-quality treatment that promotes developmental milestones like social skills, motor abilities, and school readiness. The company has demonstrated strong growth, raising over $15 million in 2021 to scale operations, earning a 3-year Behavioral Health Center of Excellence (BHCOE) accreditation in 2022, and expanding via organic growth and small acquisitions across California.[1][2][4][5]
Opya was founded in 2015 by Jonathan Wright, inspired by his mother, a dedicated adolescent psychiatrist who spent her career caring for children with severe mental illnesses. With over 20 years in healthcare and technology, Wright identified the need for better early intervention options for young children with autism, leading to Opya's creation in the San Francisco Bay Area.[2][4]
Early traction came from starting with one location and expanding to multiple geographies in California, driven by the rising demand for autism services. Pivotal moments include securing $15 million in funding in 2021 for platform scaling, achieving top-tier BHCOE accreditation on the first attempt in 2022, and recent acquisitions to add center-based care alongside in-home services. Under CEO Alden Romney, Opya has emphasized its name's "Op" for "Optimism," guided by principles of early intervention, in-home care, and connectivity.[1][2][4]
Opya's edge in autism care stems from blending clinical excellence with technology:
Opya rides the wave of digital health transformation in behavioral care, where rising autism diagnoses (1 in 36 U.S. children) meet demands for accessible, tech-enabled early intervention—98% of pediatricians agree it's essential. Its timing aligns with post-pandemic shifts to in-home services, insurance expansions for ABA, and AI/data tools for personalized medicine, positioning Opya amid market forces like provider shortages and family advocacy for quality over volume.[2][5]
By integrating tech for connectivity (e.g., mood tracking, therapist-parent links), Opya influences the ecosystem, setting standards for hybrid care models and inspiring acquisitions/partnerships. As a BIP Ventures portfolio company, it exemplifies VC-backed innovation in neurodiversity support, helping scale high-quality ABA amid a fragmented $2B+ U.S. autism therapy market.[1][3]
Opya is poised for accelerated expansion through organic growth and targeted acquisitions of quality-aligned providers, aiming to serve more California families while potentially entering new states. Trends like AI-driven personalization, telehealth integration, and broader insurance coverage for neurodiversity will fuel its trajectory, enhancing clinical outcomes and operational scale.
Its influence may evolve from regional leader to national model for tech-infused autism care, transforming lives as it began—rooted in optimism and early action for neurodiverse children.[2]
Opya has raised $19.0M in total across 2 funding rounds.
Opya's investors include Altitude Ventures, BIP Capital, Divergent Investments, Surface Ventures, Austin Poole, Raven One Ventures, SB Opportunity Fund, The Disability Opportunity Fund, Bootstrap Venture Partners, Keshif Ventures.
